Related Experiment Video
Updated: Aug 13, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Opioid tolerance and the emergence of new opioid receptor-coupled signaling
1Department of Biochemistry, State University of New York Health Science Center at Brooklyn, 11203, USA. agintzler@netmail.hscbklyn.edu
Abstract:
Multiple cellular adaptations are elicited by chronic exposure to opioids. These include diminution of spare opioid receptors, decreased opioid receptor density, and G-protein content and coupling thereof. All imply that opioid tolefance is a manifestation of a loss of opioid function, i.e., desensitization. Recent observations challenge the exclusiveness of this formulation and indicate that opioid tolerance also results from qualitative changes in opioid signaling. In this article, Gintzler and Chakrabarti discuss the evidence that suggests that opioid tolerance results not only from impaired opioid receptor functionality, but also from altered consequences of coupling. Underlying the latter are fundamental changes in the nature of effectors that are coupled to the opioid receptor/G-protein signaling pathway. These molecular changes include the upregulation of adenylyl cyclase isoforms of the type II family as well as a substantial increase in their phosphorylation state. As a result, there is a shift in opioid receptor/G-protein signaling from predominantly Gialpha inhibitory to Gbetagamma stimulatory following chronic in vivo morphine exposure. These adaptations to chronic morphine indicate the plasticity of opioid-signal transduction mechanisms and the ability of chronic morphine to augment new signaling strategies.
Insights
Opioid tolerance involves more than reduced receptor function; it also stems from altered signaling pathways. Chronic morphine exposure shifts cellular signaling, revealing the adaptive plasticity of opioid systems.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Chronic opioid exposure induces cellular adaptations like reduced receptor availability and G-protein function, traditionally viewed as opioid desensitization.
- Emerging evidence suggests opioid tolerance is also driven by qualitative alterations in opioid signaling pathways.
Purpose of the Study:
- To review evidence indicating that opioid tolerance results from both impaired receptor functionality and modified downstream signaling consequences.
- To explore the molecular underpinnings of altered opioid signaling, focusing on changes in effector molecules coupled to the opioid receptor/G-protein pathway.
Main Methods:
- Review of existing literature on cellular adaptations to chronic opioid exposure.
- Analysis of molecular changes in opioid receptor/G-protein signaling pathways, including adenylyl cyclase activity and phosphorylation states.
Main Results:
- Chronic morphine exposure leads to upregulation and increased phosphorylation of adenylyl cyclase type II isoforms.
- A significant shift in opioid receptor/G-protein signaling occurs, moving from predominantly inhibitory Gialpha to stimulatory Gbetagamma subunits.
- These adaptations highlight the plasticity of opioid signal transduction mechanisms.
Conclusions:
- Opioid tolerance is a complex phenomenon involving both desensitization and altered signaling pathways.
- Chronic morphine exposure induces adaptive changes in cellular signaling, enabling new signaling strategies and demonstrating the dynamic nature of opioid systems.
More Related Videos
07:48Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
Published on: July 3, 2015
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
Related Concept Videos
Desensitization and Tachyphylaxis
Several...
Drug Abuse and Addiction: Pharmacological Phenomena
Opioid Receptors: Overview
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids